Skip to content
10-Q

Quarterly Report

Cogent Biosciences, Inc. COGT

0000950170-25-102440

← back to feed
Filed
Aug 5, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 139.7M sh
Shares Diluted Q2 2025 · Jun 30, 2025 114.47M sh
Shares Diluted Q2 2025 · Jun 30, 2025 114.46M sh
Shares Diluted Q2 2025 · Jun 30, 2024 99.24M sh
Shares Diluted Q2 2025 · Jun 30, 2024 97.02M sh
Capex Q2 2025 · Jun 30, 2025 $678K
Capex Q2 2025 · Jun 30, 2024 $218K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$121.05M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$95.23M
Long Term Debt Q2 2025 · Jun 30, 2025 $43.95M
Long Term Debt Q2 2025 · Dec 31, 2024 $0
Cash And Equivalents Q2 2025 · Jun 30, 2025 $127.6M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $98.17M
Stockholders Equity Q2 2025 · Jun 30, 2025 $155.04M
Stockholders Equity Q2 2025 · Mar 31, 2025 $219M
Stockholders Equity Q2 2025 · Dec 31, 2024 $256.29M
Stockholders Equity Q2 2025 · Jun 30, 2024 $373.22M
Stockholders Equity Q2 2025 · Mar 31, 2024 $422.33M
Stockholders Equity Q2 2025 · Dec 31, 2023 $257.8M
Current Liabilities Q2 2025 · Jun 30, 2025 $58.42M
Current Liabilities Q2 2025 · Dec 31, 2024 $55.71M
Total Liabilities Q2 2025 · Jun 30, 2025 $119.78M
Total Liabilities Q2 2025 · Dec 31, 2024 $71.61M
Current Assets Q2 2025 · Jun 30, 2025 $245.01M
Current Assets Q2 2025 · Dec 31, 2024 $296.47M
Total Assets Q2 2025 · Jun 30, 2025 $274.82M
Total Assets Q2 2025 · Dec 31, 2024 $327.9M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.53
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.05
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$0.43
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$0.91
Eps Basic Q2 2025 · Jun 30, 2025 −$0.53
Eps Basic Q2 2025 · Jun 30, 2025 −$1.05
Eps Basic restated Q2 2025 · Jun 30, 2024 −$0.43
Eps Basic restated Q2 2025 · Jun 30, 2024 −$0.91
Sga Expense Q2 2025 · Jun 30, 2025 $13.38M
Sga Expense Q2 2025 · Jun 30, 2025 $25.28M
Sga Expense Q2 2025 · Jun 30, 2024 $10.09M
Sga Expense Q2 2025 · Jun 30, 2024 $19.79M
Rd Expense Q2 2025 · Jun 30, 2025 $62.2M
Rd Expense Q2 2025 · Jun 30, 2025 $125.23M
Rd Expense Q2 2025 · Jun 30, 2024 $54.29M
Rd Expense Q2 2025 · Jun 30, 2024 $107M
Net Income Q2 2025 · Jun 30, 2025 −$73.53M
Net Income Q2 2025 · Jun 30, 2025 −$145.52M
Net Income Q2 2025 · Mar 31, 2025 −$71.99M
Net Income Q2 2025 · Jun 30, 2024 −$58.95M
Net Income Q2 2025 · Jun 30, 2024 −$117.3M
Net Income Q2 2025 · Mar 31, 2024 −$58.35M
Operating Income Q2 2025 · Jun 30, 2025 −$75.58M
Operating Income Q2 2025 · Jun 30, 2025 −$150.52M
Operating Income Q2 2025 · Jun 30, 2024 −$64.39M
Operating Income Q2 2025 · Jun 30, 2024 −$126.79M